NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Cypress Semiconductor Corporation (NASDAQ: CY) resulting from allegations that Cypress may have issued materially misleading business information to the investing public.
On March 3, 2020, the Food and Drug Administration (“FDA”) issued a news release “informing patients, health care providers and manufacturers about a set of cybersecurity vulnerabilities, referred to as ‘SweynTooth,’ that—if exploited—may introduce risks for certain medical devices.” The FDA named Cypress as one “of several manufacturers that are affected by these vulnerabilities.”
On this news, Cypress’s stock price fell sharply over the following trading sessions.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Cypress investors. If you purchased Cypress securities, please visit the firm’s website at http://www.rosenlegal.com/cases-register-1819.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.